| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/18/1999 | CA2299171A1 Use of a 2-amino-alkane polyol as agent for treating skin ageing signs |
| 02/18/1999 | CA2298849A1 Lipoprotein-regulating medicaments |
| 02/18/1999 | CA2298824A1 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases |
| 02/18/1999 | CA2298779A1 Use of nk-1 receptor antagonists for treating aggressive behaviour disorders |
| 02/18/1999 | CA2298777A1 Use of nk-1 receptor antagonists for treating mania |
| 02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2298701A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2298679A1 Isoflavone-containing compositions |
| 02/18/1999 | CA2298651A1 1-¬4-(substituted alkoxy)benzyl|naphthalene compounds having estrogen inhibitory activity |
| 02/18/1999 | CA2298586A1 Immunity suppression by photochemotherapy |
| 02/18/1999 | CA2297967A1 Purine inhibitor of protein kinases, g proteins and polymerases |
| 02/18/1999 | CA2297889A1 Alpha 1a adrenergic receptor antagonist |
| 02/18/1999 | CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6 |
| 02/18/1999 | CA2297412A1 Anthranilic acid analogs |
| 02/18/1999 | CA2297409A1 Anthranilic acid analogs |
| 02/18/1999 | CA2297290A1 Chemical compounds |
| 02/18/1999 | CA2297174A1 Aqueous aerosol preparations containing biologically active macromolecules and process for producing the corresponding aerosols |
| 02/18/1999 | CA2295620A1 5,6-heteroaryl-dipyrido¬2,3-b:3',2'-f|azepines and their use in the prevention or treatment of hiv infection |
| 02/18/1999 | CA2295535A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 02/18/1999 | CA2268030A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897007A2 MraY transferase |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896821A1 A novel pharmaceutical composition for inhalation containing CR 2039 (andolast) |
| 02/17/1999 | EP0896820A1 Ophthalmic composition comprising naloxone and at least one polyhydric alcohol |
| 02/17/1999 | EP0896819A1 Antiglucocorticoid drug |
| 02/17/1999 | EP0896818A1 Improved rapidly disintegratable multiparticulate tablet |
| 02/17/1999 | EP0896817A1 A zinc containing oral preparation and a procell for preparing it |
| 02/17/1999 | EP0896815A1 Suspension of sparingly water-soluble acidic drug |
| 02/17/1999 | EP0896792A1 Antiviral agent |
| 02/17/1999 | EP0896626A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 02/17/1999 | EP0896625A2 Recombinant ribonuclease proteins |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896621A2 Cftr gene regulator |
| 02/17/1999 | EP0896586A1 ErbB3 ANTIBODIES |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896580A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 02/17/1999 | EP0896578A1 NOVEL IMIDAZO 1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 02/17/1999 | EP0896577A1 Taxane derivatives having a pyridil substituted c13 side chain, their preparation and their use as anti-tumor agents |
| 02/17/1999 | EP0896543A1 Drug for the treatment of tumours |
| 02/17/1999 | EP0896540A1 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression |
| 02/17/1999 | EP0896539A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 02/17/1999 | EP0896538A1 Use of dipeptidyl peptidase iv inhibitors for lowering the blood glucose level in mammals |
| 02/17/1999 | EP0896537A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 02/17/1999 | EP0896536A1 Use of lofexidine in the manufacture of a medicament for treating attention deficit hyperactive disorder |
| 02/17/1999 | EP0896535A1 Use of substituted aryl imidazoles |
| 02/17/1999 | EP0896534A1 Injection formulations of avermectins and milbemycins based on castor oil |
| 02/17/1999 | EP0896533A2 Pentafluorobenzenesulfonamides and analogs |
| 02/17/1999 | EP0896532A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals |
| 02/17/1999 | EP0896531A1 Il-8 receptor antagonists |
| 02/17/1999 | EP0896530A1 Dosage forms and uses |
| 02/17/1999 | EP0896529A1 Estradiol and progesterone-based medicament |
| 02/17/1999 | EP0896526A1 Agglomerates containing beta-lactam compounds |
| 02/17/1999 | EP0896525A1 Methods of dry powder inhalation |
| 02/17/1999 | EP0896522A1 Methods of regulating skin appearance with vitamin b 3? compound |
| 02/17/1999 | EP0896521A1 Composition, barrier film, and method for preventing contact dermatitis |
| 02/17/1999 | EP0896516A1 Diabetic supplement bar |
| 02/17/1999 | EP0896506A1 Methods for inducing immune responsiveness in a subject |
| 02/17/1999 | EP0633774B1 Topical administration of toremifene and its metabolites |
| 02/17/1999 | EP0516777B1 Brain resuscitation device |
| 02/17/1999 | CN1208420A Antisecretory factor peptides regulating pathological permeability changes |
| 02/17/1999 | CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208416A Isooxacephem derivatives |
| 02/17/1999 | CN1208415A Angiogenesis inhibiting pyridazinamines |
| 02/17/1999 | CN1208413A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208411A Benzofuran carboxamides and sulphonamides |
| 02/17/1999 | CN1208409A Novel benzoyl guanidine derivatives process for their preparation and their use in the preparation of medicines |
| 02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
| 02/17/1999 | CN1208404A Nitrogenous heterocyclic compounds |
| 02/17/1999 | CN1208403A Compounds |
| 02/17/1999 | CN1208402A Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 02/17/1999 | CN1208351A Composition containing diosgenin |
| 02/17/1999 | CN1208350A High-content famciclovir tablets |
| 02/17/1999 | CN1208349A Composition for treating pain |
| 02/17/1999 | CN1208348A Method for treating pain |
| 02/17/1999 | CN1208347A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 02/17/1999 | CN1208346A Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors |
| 02/17/1999 | CN1208345A Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 02/17/1999 | CN1208338A Composition and method for acceleration of wound and burn healing |
| 02/17/1999 | CN1208043A Crystalline progestagens |
| 02/17/1999 | CN1208035A Dithiolan derivatives, their preparation and their therapeutic effect |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1208033A Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities |
| 02/17/1999 | CN1207946A Thioether conjugates |
| 02/17/1999 | CN1207922A Antiphlogistic healing ointment for curing surgical infection |
| 02/17/1999 | CN1207898A Simethicone/anhydrous calcium phosphate compositions |
| 02/17/1999 | CN1207897A External-use medicine for surgical infection |
| 02/17/1999 | CN1207896A Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/17/1999 | CN1207895A Clarithromycin capsule |
| 02/17/1999 | CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/17/1999 | CN1042132C 8-amino-10-(azabicycloalkyl)-pyrido (1,2,3-D,E) (1,3,4) benzoxadiazine derivatives |
| 02/17/1999 | CN1042130C 4-oxo-azetidin-2-sulfonic-acid-amide and salt of same, preparation and application of same |
| 02/17/1999 | CN1042097C Cosmetic product having a stabilized redox potential |